Sources and updates, June 26

June 26, 2022.Reading time 3 minutes.

Sources and updates for the week of June 26 include Paxlovid distribution, booster shot uptake, and a guide to government COVID-19 documents.

0 Shares

We need more data on who’s getting Paxlovid

May 29, 2022.Reading time 11 minutes.

Last week, I shared a new page from the Department of Health and Human Services (HHS), reporting statistics on COVID-19 therapeutic distribution in the U.S. The new dataset is a helpful step, but it falls far short of the information we actually need to examine who has access to COVID-19 treatments (particularly Paxlovid) and address potential health equity issues.

0 Shares

Contracted staffing issues in Missouri reveal broader crisis in hospitals

March 6, 2022.Reading time 7 minutes.

Early this week, I had a big story published in The Missouri Independent, as part of the Documenting COVID-19 project’s ongoing collaboration with that nonprofit newsroom. While this was a local story, to me, the piece provides important insights about the type of support that is actually needed in U.S. hospitals right now: not temporary assistance, but long-term, structural change.

0 Shares

First COVID-19 antiviral pill gains authorization

November 7, 2021.Reading time 4 minutes.

This week, an antiviral pill for COVID-19 was authorized in the U.K. The drug, made by American pharmaceutical company Merck, is the first COVID-19 treatment in pill form to gain approval by any regulatory agency.

0 Shares